Hydroxychloroquine is associated with a lower risk of polyautoimmunity: data from the RELESSER Registry

Abstract

Patients with SLE frequently present polyautoimmunity. We observed clinical and analytical characteristics associated with polyautoimmunity. Our finding that antimalarial drugs protected against polyautoimmunity should be verified in future studies.